ES2042723T3 - Un procedimiento para preparar una composicion farmaceutica granular. - Google Patents

Un procedimiento para preparar una composicion farmaceutica granular.

Info

Publication number
ES2042723T3
ES2042723T3 ES88202909T ES88202909T ES2042723T3 ES 2042723 T3 ES2042723 T3 ES 2042723T3 ES 88202909 T ES88202909 T ES 88202909T ES 88202909 T ES88202909 T ES 88202909T ES 2042723 T3 ES2042723 T3 ES 2042723T3
Authority
ES
Spain
Prior art keywords
preparing
procedure
pharmaceutical composition
granular pharmaceutical
taste
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES88202909T
Other languages
English (en)
Inventor
Eberhard Fritz Gottwald
Hermann Peter Osterwald
Horst Manfred Machoczek
David Mayron
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Dauelsberg GmbH
Original Assignee
SmithKline Dauelsberg GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Dauelsberg GmbH filed Critical SmithKline Dauelsberg GmbH
Application granted granted Critical
Publication of ES2042723T3 publication Critical patent/ES2042723T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Biophysics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

LA PRESENTE INVENCION SE REFIERE A UN COMPUESTO FARMACEUTICO GRANULAR QUE COMPRENDE CIMETIDINA Y COMO AGENTE GRAQNUILANTE Y AGENTE QUE ENMASCARA EL SABOR UN ESTER DE UN COMPUESTO POLIHIDROXIL, Y DONDE SE DESEA UNA EMULSION SABROSA ACEPTABLE FARMACEUTICAMENTE. LOS ESTERES EN PARTICULAR SON ESTERES DE GLICEROL. LOS GRANULOS DE LA PRESXENTE INVENCION PUEDEN UTILIZARSE EN LA PREPARACION DE PASTILLAS QUE TIENEN UNA BUENA BIOEFICACIA Y SABOR.
ES88202909T 1987-12-23 1988-12-16 Un procedimiento para preparar una composicion farmaceutica granular. Expired - Lifetime ES2042723T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB878730011A GB8730011D0 (en) 1987-12-23 1987-12-23 Pharmaceutical compositions

Publications (1)

Publication Number Publication Date
ES2042723T3 true ES2042723T3 (es) 1993-12-16

Family

ID=10628958

Family Applications (1)

Application Number Title Priority Date Filing Date
ES88202909T Expired - Lifetime ES2042723T3 (es) 1987-12-23 1988-12-16 Un procedimiento para preparar una composicion farmaceutica granular.

Country Status (15)

Country Link
US (1) US5057319A (es)
EP (1) EP0322048B1 (es)
JP (1) JP2840097B2 (es)
AT (1) ATE77236T1 (es)
AU (1) AU605671B2 (es)
CA (1) CA1313140C (es)
DE (1) DE3872199T2 (es)
DK (1) DK415689A (es)
ES (1) ES2042723T3 (es)
GB (1) GB8730011D0 (es)
GR (1) GR3005640T3 (es)
IE (1) IE60966B1 (es)
PT (1) PT89260B (es)
WO (1) WO1989005640A1 (es)
ZA (1) ZA889441B (es)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5578322A (en) * 1990-11-30 1996-11-26 Yamanouchi Pharmaceutical Co., Ltd. Quick release coated preparation
US5629013A (en) * 1991-04-04 1997-05-13 The Procter & Gamble Company Chewable calcium carbonate antacid tablet compositions
US5380535A (en) * 1991-05-28 1995-01-10 Geyer; Robert P. Chewable drug-delivery compositions and methods for preparing the same
DK0587744T3 (da) * 1991-05-28 2003-10-20 Mcneil Ppc Inc Tygbar sammensætning til frigørelse af et lægemiddel
GB9127150D0 (en) * 1991-12-20 1992-02-19 Smithkline Beecham Plc Novel treatment
AU2584092A (en) * 1992-09-03 1994-03-29 Affinity Biotech, Inc. Taste-masking pharmaceutical compositions and methods for making the same
CA2146999A1 (en) * 1992-10-16 1994-04-28 Stephen John Douglas Taste-masking compositions of ranitidine
GB9224855D0 (en) * 1992-11-27 1993-01-13 Smithkline Beecham Plc Pharmaceutical compositions
KR950703935A (ko) * 1992-11-30 1995-11-17 밋첼 아이, 커시너 맛을 차단하는 약제학적 조성물
US5622980A (en) * 1993-08-17 1997-04-22 Applied Analytical Industries, Inc. Oral compositions of H2-antagonists
JP3601071B2 (ja) * 1994-03-11 2004-12-15 不二製油株式会社 ブルーム防止剤並びにこれを含有するラウリン系油脂及びチョコレート類
AUPN862596A0 (en) * 1996-03-12 1996-04-04 F.H. Faulding & Co. Limited Pharmaceutical compositions
US6537525B1 (en) * 1997-01-29 2003-03-25 Douglas H. West Medicated chewing-gum
CA2305179A1 (en) * 1997-09-30 1999-04-08 Daiichi Pharmaceutical Co., Ltd. Oral administration preparation
US5891476A (en) * 1997-12-22 1999-04-06 Reo; Joe P. Tastemasked pharmaceutical system
FR2784895B1 (fr) * 1998-10-23 2004-12-17 Gattefosse Ets Sa Comprime a croquer a gout masque et liberation immediate du principe actif et procede de fabrication
US6248363B1 (en) * 1999-11-23 2001-06-19 Lipocine, Inc. Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
US7510728B2 (en) 2000-10-06 2009-03-31 Takeda Pharmaceutical Company Limited Solid preparations
US20040115287A1 (en) * 2002-12-17 2004-06-17 Lipocine, Inc. Hydrophobic active agent compositions and methods
US7282217B1 (en) 2003-08-29 2007-10-16 Kv Pharmaceutical Company Rapidly disintegrable tablets
AU2007295179B2 (en) * 2006-09-15 2013-05-30 Echo Pharmaceuticals B.V. Dosage unit for sublingual, buccal or oral administration of water-insoluble pharmaceutically active substances
AU2007295178B2 (en) * 2006-09-15 2013-04-18 Echo Pharmaceuticals B.V. Granulate containing a pharmaceutically active substance and anemulsifier and method for its manufacture
US9375437B2 (en) 2010-06-18 2016-06-28 Lipocine Inc. Progesterone containing oral dosage forms and kits
US9034858B2 (en) 2010-11-30 2015-05-19 Lipocine Inc. High-strength testosterone undecanoate compositions
US20180153904A1 (en) 2010-11-30 2018-06-07 Lipocine Inc. High-strength testosterone undecanoate compositions
US9358241B2 (en) 2010-11-30 2016-06-07 Lipocine Inc. High-strength testosterone undecanoate compositions
US20120148675A1 (en) 2010-12-10 2012-06-14 Basawaraj Chickmath Testosterone undecanoate compositions
US8951996B2 (en) 2011-07-28 2015-02-10 Lipocine Inc. 17-hydroxyprogesterone ester-containing oral compositions and related methods
US20170246187A1 (en) 2014-08-28 2017-08-31 Lipocine Inc. (17-ß)-3-OXOANDROST-4-EN-17-YL TRIDECANOATE COMPOSITIONS AND METHODS OF THEIR PREPARATION AND USE
US9498485B2 (en) 2014-08-28 2016-11-22 Lipocine Inc. Bioavailable solid state (17-β)-hydroxy-4-androsten-3-one esters
US20160361322A1 (en) 2015-06-15 2016-12-15 Lipocine Inc. Composition and method for oral delivery of androgen prodrugs
ES3005883T3 (en) 2015-06-22 2025-03-17 Lipocine Inc 17-hydroxyprogesterone ester-containing oral compositions and related methods
US20180147215A1 (en) 2016-11-28 2018-05-31 Lipocine Inc. Oral testosterone undecanoate therapy
US12150945B2 (en) 2018-07-20 2024-11-26 Lipocine Inc. Liver disease

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3308217A (en) * 1965-02-09 1967-03-07 Lowy Lawrence Method of granulating materials for subsequent forming into tablets
FR2253507A1 (en) * 1973-12-11 1975-07-04 Houdet Antoine Vincamine administration using delayed release excipient - allowing prolonged action
US4256108A (en) * 1977-04-07 1981-03-17 Alza Corporation Microporous-semipermeable laminated osmotic system
JPS6029682B2 (ja) * 1980-07-11 1985-07-12 山之内製薬株式会社 苦味のない製剤用組成物およびその製造法
MTP930B (en) * 1982-04-30 1984-04-10 Delandale Labs Ltd Substained release lithium-containing tablets and method for their manufacture
US4851228A (en) * 1984-06-20 1989-07-25 Merck & Co., Inc. Multiparticulate controlled porosity osmotic
US4755387A (en) * 1985-03-21 1988-07-05 The Procter & Gamble Company Therapeutic particles
DE3524003A1 (de) * 1985-07-04 1987-01-08 Heumann Ludwig & Co Gmbh Arzneimittelgranulat mit verzoegerter wirkstofffreisetzung und verfahren zu seiner herstellung
FR2593065B1 (fr) * 1986-01-22 1988-09-09 Smith Kline French Lab Couples effervescents, compositions effervescentes d'antagonistes h2 de l'histamine les contenant et leur preparation.
GB2195890A (en) * 1986-10-06 1988-04-20 Procter & Gamble Improving palatability of pharmaceutical chewable tablets
GB2195891A (en) * 1986-10-06 1988-04-20 Procter & Gamble Improving palatability of pharmaceutical chewable tablets
US4786502A (en) * 1986-10-06 1988-11-22 The Procter & Gamble Company Palatable solid pharmaceutical compositions
US4892778A (en) * 1987-05-27 1990-01-09 Alza Corporation Juxtaposed laminated arrangement
US4824675A (en) * 1987-07-13 1989-04-25 Alza Corporation Dispenser with movable matrix comprising a plurality of tiny pills
US4814183A (en) * 1987-08-31 1989-03-21 Merck & Co., Inc. Device for the controlled release of drugs with Donnan-like modulation by charged insoluble resins
EP0349103B1 (en) * 1988-05-04 1992-11-25 Smith Kline & French Laboratories Limited Chewable tablet

Also Published As

Publication number Publication date
PT89260B (pt) 1993-07-30
GR3005640T3 (es) 1993-06-07
WO1989005640A1 (en) 1989-06-29
IE60966B1 (en) 1994-09-07
EP0322048A1 (en) 1989-06-28
ZA889441B (en) 1989-12-27
ATE77236T1 (de) 1992-07-15
CA1313140C (en) 1993-01-26
DK415689D0 (da) 1989-08-23
IE883843L (en) 1989-06-23
US5057319A (en) 1991-10-15
DE3872199D1 (de) 1992-07-23
AU605671B2 (en) 1991-01-17
PT89260A (pt) 1989-12-29
EP0322048B1 (en) 1992-06-17
DK415689A (da) 1989-08-23
JP2840097B2 (ja) 1998-12-24
GB8730011D0 (en) 1988-02-03
DE3872199T2 (de) 1992-12-17
AU2915789A (en) 1989-07-19
JPH02502729A (ja) 1990-08-30

Similar Documents

Publication Publication Date Title
ES2153385T3 (es) Composicion acuosa a base de hormona del crecimiento humana.
SE8303531D0 (sv) Farmaceutisk komposition
ES424533A1 (es) Metodo de prolongar la disponibilidad de sustancias farmaco-logicamente activas incluidas en composiciones farmaceuticasa base de alcohol alifatico e hidroxialcohilcelulosa.
YU86001A (sh) Novi preparat i oblik, u kojem se daje lek, koji sadrži aktivno jedinjenje labilno prema kiselini
EP0165352A3 (en) Clear micellized solutions of fat soluble essential nutrients
GB1546448A (en) Sustained-release formulations
ES2171933T3 (es) Derivados de androsteno.
DE2964963D1 (en) Medical food based on liver powder and process for its preparation
MX172804B (es) Composicion de cebo para insectos en forma de tableta y procedimiento para su preparacion
IE791806L (en) Gastroprotective mollusc extract
NO173046C (no) Fremgangsmaate for fremstilling av terapeutiske preparaterinneholdende 2-(2-fluor-4-bifenylyl)propionsyre
ATE14981T1 (de) Pharmazeutisches praeparat und seine herstellung.
JPS5423115A (en) Gamma-globulin for intravenous injection and its preparation
NO962129L (no) Ny farmasöytisk blanding for fremstilling av et stabilt pulver inneholdende et aktivt prinsipp omfattende en forbindelse av acetylsalicylsyre og metoklopramid
ES8400028A1 (es) Metodo de preparacion de una composicion tixotropica anhidra.
JPS565465A (en) Benzimidazole derivative* its manufacture and medicinal composition of same as active component
MX174407B (es) Tableta y granulado que contienen mesna como su stancia activa
ES2057724T3 (es) Preparado de queso fundido.
ES8800040A1 (es) Procedimiento para la obtencion de una composicion farmaceutica de liberacion retardada a base de 9,10-dihidro-alcaloides.
ES451880A1 (es) Procedimiento de preparacion de una nueva composicion den- tifrica.
Hakim et al. Experimental toxicologic studies on 8-methoxypsoralen in animals exposed to the long ultraviolet
JPS5764609A (en) Cyclophosphamide composition for rectal administration
US2854376A (en) Antacid composition
SE8301565D0 (sv) Oljeloslig komposition innehallande fettloslig vitamin
SE8401748D0 (sv) Antimykotiskt medel i form av krem med hoggradig frigoring av verksam substans

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 322048

Country of ref document: ES